Key References
- Chakrabarti, JK Curr. Opin. Thera. Patents 1991 1 1 3–16.
- Salmon, JA Garland, LG Drug Research 1991 37 9–90.
- Batt, DG Progress in Medicinal Chemistry 1992 29 1–63.
- Musser, JH Kreft, AF J. Med. Chem. 1992 35 2501–2524.
- McMillan, RM Walker, ER H TIPS 1992 13 323–330.
- Flynn, DL Capiris, T Cetenko, WJ Connor, DT J. Med. Chem. 1990 33 2070–2072.
- Vaananen, PM Keenan Grisham, MB Wallace, JL Inflammation 1992 16 227–240.
- Asako, H Kubes, P Wallace, JL Am. J. Physiol. 1992 262 G903–908.
- Laursen, LS Naesdal, J Bukhave, K Lancet 1990 335 683–685.
- Rask-Masden, J Bukhave, K Laursen, LS Lauritsen, K Agents and Actions 1992 C37–C46.
- Bell, RL Young, PR Albert, D Int. J. Immunopharmacol. 1992 14 505–510.
- Bayer US 5126354.
- Bayer EP-509359-A.